These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21607564)
1. Role of gonadal hormones on mu-opioid-stimulated [³⁵S]GTPγS binding and morphine-mediated antinociception in male and female Sprague-Dawley rats. Peckham EM; Graves SM; Jutkiewicz E; Becker JB; Traynor JR Psychopharmacology (Berl); 2011 Dec; 218(3):483-92. PubMed ID: 21607564 [TBL] [Abstract][Full Text] [Related]
2. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. Wang YJ; Huang P; Blendy JA; Liu-Chen LY Addict Biol; 2014 May; 19(3):354-61. PubMed ID: 22862850 [TBL] [Abstract][Full Text] [Related]
3. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord. Madia PA; Navani DM; Yoburn BC Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651 [TBL] [Abstract][Full Text] [Related]
4. Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus. Selley DE; Cao CC; Liu Q; Childers SR Br J Pharmacol; 2000 Jul; 130(5):987-96. PubMed ID: 10882382 [TBL] [Abstract][Full Text] [Related]
5. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study. Chen F; Lawrence AJ J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165 [TBL] [Abstract][Full Text] [Related]
6. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. Maher CE; Selley DE; Childers SR Biochem Pharmacol; 2000 Jun; 59(11):1395-401. PubMed ID: 10751548 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532 [TBL] [Abstract][Full Text] [Related]
8. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice. Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837 [TBL] [Abstract][Full Text] [Related]
9. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors. Smith PA; Selley DE; Sim-Selley LJ; Welch SP Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035 [TBL] [Abstract][Full Text] [Related]
10. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception. Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076 [TBL] [Abstract][Full Text] [Related]
11. Mu opioid receptor signaling in morphine sensitization. Viganò D; Rubino T; Di Chiara G; Ascari I; Massi P; Parolaro D Neuroscience; 2003; 117(4):921-9. PubMed ID: 12654343 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. Peckham EM; Traynor JR J Pharmacol Exp Ther; 2006 Mar; 316(3):1195-201. PubMed ID: 16291875 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration. Maher CE; Martin TJ; Childers SR Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372 [TBL] [Abstract][Full Text] [Related]
14. Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain. Selley DE; Herbert JT; Morgan D; Cook CD; Picker MJ; Sim-Selley LJ Brain Res Bull; 2003 May; 60(3):201-8. PubMed ID: 12754081 [TBL] [Abstract][Full Text] [Related]
15. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Xie H; Woods JH; Traynor JR; Ko MC Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626 [TBL] [Abstract][Full Text] [Related]
16. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox. Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823 [TBL] [Abstract][Full Text] [Related]
19. Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats. Stoffel EC; Ulibarri CM; Folk JE; Rice KC; Craft RM J Pain; 2005 Apr; 6(4):261-74. PubMed ID: 15820914 [TBL] [Abstract][Full Text] [Related]
20. Chronic in utero morphine exposure alters mu-agonist-stimulated [35S]-GTPgammaS binding in neonatal and juvenile guinea pig brainstem regions associated with breathing control. Matsuda AY; Olsen GD Neurotoxicol Teratol; 2001; 23(5):413-9. PubMed ID: 11711243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]